Seelos Therapeutics, INC.: insider trades · United States · SEC (Form 4)

Discover the full management transaction log of Seelos Therapeutics, INC., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Seelos Therapeutics, INC. has logged 4 public disclosures. Market capitalisation: €58. The latest transaction was reported on 2 June 2022 (Acquisition). Among the most active insiders: O'Connor Daniel J.. Every trade is accessible without an account.